Validation of an allergic rhinitis control test for children
Validation of an Allergic Rhinitis Control Test in Children
This study is testing a new questionnaire for parents to help check how well treatments are working for children aged 5 to 11 with allergic rhinitis.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 135 (estimated) |
| Ages | 5 Years to 11 Years |
| Sex | All |
| Sponsor | University Hospital, Montpellier Academic / other |
| Locations | 6 sites (Bagnols-sur-Cèze and 5 other locations) |
| Trial ID | NCT03075917 on ClinicalTrials.gov |
What this trial studies
This study aims to adapt a previously validated self-administered control test for allergic rhinitis to a pediatric population aged 5 to 11 years. By assessing the control of allergic rhinitis in children, the study seeks to improve treatment satisfaction and quality of life for young patients suffering from this condition. The intervention involves a self-questionnaire that parents will help their children complete, ensuring accurate reporting of symptoms and treatment effectiveness. The goal is to provide a validated tool that can be used in clinical practice to better manage allergic rhinitis in children.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 5 to 11 years who are consulting a practitioner for allergic rhinitis.
Not a fit: Patients who are currently treated for an episode of allergic rhinitis and are satisfied with their treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and treatment satisfaction for children suffering from allergic rhinitis.
How similar studies have performed: Previous studies have validated similar assessment tools for allergic rhinitis in older populations, but this adaptation for younger children is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 5 to 11 years old, consulting a practitioner for an allergic rhinitis * Parents formulated their study participation agreement by signing the consent form. Exclusion Criteria: * Patients that are already treated for the actual episode of allergic rhinitis and are satisfied of the treatment.
Where this trial is running
Bagnols-sur-Cèze and 5 other locations
- CH Louis Pasteur — Bagnols-sur-Cèze, France (Completed)
- Maison de santé de Lasalle — Lasalle, France (Terminated)
- CH de MILLAU — Millau, France (Completed)
- Centre (Ctre) Medical Ravas - Malbosc — Montpellier, France (Completed)
- University hospital of Montpellier — Montpellier, France (Recruiting)
- Hôpital Trousseau, — Paris, France (Completed)
Study contacts
- Study coordinator: Pascal DEMOLY, Professor
- Email: pascal.demoly@inserm.fr
- Phone: +334 67 33 61 27
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.